Use of benzodiazepines in panic disorder

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 2, 1997, Pages 26-28

  Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CLONAZEPAM; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; LORAZEPAM;

ATAXIA; CLINICAL TRIAL; CONSTIPATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; HUMAN; LIBIDO; META ANALYSIS; PANIC; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEDATION; SLURRED SPEECH;

ALPRAZOLAM; BENZODIAZEPINES; CLONAZEPAM; HUMANS; LORAZEPAM; PANIC DISORDER; TREATMENT OUTCOME;

EID: 0030901307     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Schapira K, Roth M, Kerr TA, et al. The prognosis of affective disorders: the differentiating of anxiety states from depressive illnesses. Br J Psychiatry 1972;121:175-181
2. Markovitz JS, Weissmann MM, Ouellette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry 1989;46:984-992
3. Sheehan DV, Ballenger JC, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51-59
4. Ballenger JC, Burrows G, DuPont RL, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter study. Arch Gen Psychiatry 1988;45:413-422
5. Hoehn-Saric R, McLeod DR, Hipsley PA. Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993;13:321-326
6. Cross-National Collaborative Study, second phase investigators. Drug treatment of panic disorder: comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 1992;160:191-201
7. Woods SW, Nagy LM, Koleszar AS, et al. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder. J Clin Psychopharmacol 1992;12:32-38
8. Andersch S, Rosenberg NK, Kullingsjo H, et al. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder: a Scandinavian multicenter study. Acta Psychiatr Scand 1991;365(suppl): 18-27
9. Schweitzer E, Rickels K, Weiss S, et al. Maintenance drug treatment of panic disorder, I: results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Arch Gen Psychiatry 1993;50:51-60
10. Lesser IM, Rubin RT, Pecknold JC, et al. Secondary depression in panic disorder and agoraphobia. Arch Gen Psychiatry 1988;45: 437-443
11. Schweitzer E, Patterson W, Rickels K, et al. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam. Am J Psychiatry 1993;150:1210-1215
12. Rickels K, Schweitzer EE. Benzodiazepines for treatment of panic attacks: a new look. Psychopharmacol Bull 1986;23:93-99
13. Tesar GE, Rosenbaum JF, Pollack MH, et al. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry 1991;52:69-76
14. Noyes R, DuPont RL, Pecknold JC, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, II: patient acceptance, side effects, and safety. Arch Gen Psychiatry 1988;45:423-428
15. Pecknold JC, Swinson RP, Kuch K, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Arch Gen Psychiatry 1988; 45:429-436
16. Rickels K, Schweitzer E, Weiss S, et al. Maintenance drug treatment for panic disorder, II: short- and long-term outcome after drug taper. Arch Gen Psychiatry 1993;50:61-68
17. Davidson JRT. Continuation treatment of panic disorder with high-potency benzodiazepines. J Clin Psychiatry 1990;5(12, suppl A):31-37
18. Fux M, Taub M, Zohar J. Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors. Acta Psychiatr Scand 1993;88:235-237
19. Black DW, Wesner R, Gabel J, et al. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993;54: 146-149
20. Louie AK, Louie EK, Lannon RA. Systemic hypertension associated with tricyclic antidepressant treatment in patients with panic disorder. Am J Cardiol 1992;70:1306-1309
21. Taylor CB, Hayward C, King R, et al. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. J Clin Psychopharmacol 1990;10:112-118